ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Balance Sheet
Balance Sheet Decomposition
ASKA Pharmaceutical Holdings Co Ltd
Current Assets | 56.1B |
Cash & Short-Term Investments | 17.2B |
Receivables | 15.6B |
Other Current Assets | 23.3B |
Non-Current Assets | 34.6B |
Long-Term Investments | 15.7B |
PP&E | 11.3B |
Intangibles | 2.9B |
Other Non-Current Assets | 4.8B |
Current Liabilities | 24B |
Accounts Payable | 7.4B |
Accrued Liabilities | 1.2B |
Short-Term Debt | 300m |
Other Current Liabilities | 15.1B |
Non-Current Liabilities | 4.8B |
Long-Term Debt | 4.5B |
Other Non-Current Liabilities | 342m |
Balance Sheet
ASKA Pharmaceutical Holdings Co Ltd
Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
5 462
|
14 761
|
10 221
|
10 982
|
7 294
|
10 514
|
12 103
|
14 505
|
13 738
|
|
Cash Equivalents |
5 462
|
14 761
|
10 221
|
10 982
|
7 294
|
10 514
|
12 103
|
14 505
|
13 738
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
5 000
|
3 400
|
3 500
|
|
Total Receivables |
8 555
|
9 485
|
10 400
|
11 022
|
13 792
|
13 153
|
14 482
|
15 217
|
15 579
|
|
Accounts Receivables |
8 555
|
9 485
|
10 400
|
11 022
|
13 792
|
13 153
|
14 482
|
15 217
|
15 579
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
11 125
|
10 683
|
11 868
|
14 005
|
14 042
|
14 372
|
15 060
|
17 687
|
20 402
|
|
Other Current Assets |
1 736
|
2 130
|
2 329
|
1 820
|
2 198
|
1 893
|
2 912
|
2 950
|
2 924
|
|
Total Current Assets |
26 878
|
37 059
|
34 818
|
37 829
|
37 326
|
39 932
|
49 557
|
53 759
|
56 143
|
|
PP&E Net |
13 801
|
12 829
|
12 129
|
13 573
|
13 539
|
12 675
|
10 936
|
10 796
|
11 263
|
|
PP&E Gross |
13 801
|
12 829
|
12 129
|
13 573
|
13 539
|
12 675
|
10 936
|
10 796
|
11 263
|
|
Accumulated Depreciation |
28 323
|
29 284
|
30 073
|
30 721
|
31 792
|
32 504
|
24 244
|
25 042
|
23 344
|
|
Intangible Assets |
368
|
3 491
|
1 140
|
9 598
|
9 368
|
11 893
|
817
|
792
|
767
|
|
Goodwill |
2 928
|
0
|
2 219
|
5 734
|
4 216
|
0
|
5 366
|
3 673
|
2 110
|
|
Long-Term Investments |
8 985
|
8 714
|
11 747
|
11 052
|
9 794
|
12 503
|
12 223
|
14 385
|
15 654
|
|
Other Long-Term Assets |
4 518
|
4 033
|
4 182
|
4 408
|
5 996
|
5 579
|
4 398
|
3 733
|
4 808
|
|
Other Assets |
2 928
|
0
|
2 219
|
5 734
|
4 216
|
0
|
5 366
|
3 673
|
2 110
|
|
Total Assets |
57 478
N/A
|
66 126
+15%
|
66 235
+0%
|
82 194
+24%
|
80 239
-2%
|
82 582
+3%
|
83 297
+1%
|
87 138
+5%
|
90 745
+4%
|
|
Liabilities | ||||||||||
Accounts Payable |
3 784
|
5 309
|
5 217
|
7 107
|
6 040
|
6 455
|
6 841
|
5 860
|
7 355
|
|
Accrued Liabilities |
958
|
1 069
|
1 086
|
895
|
997
|
1 151
|
1 188
|
1 166
|
1 225
|
|
Short-Term Debt |
1 650
|
450
|
450
|
450
|
450
|
350
|
300
|
300
|
300
|
|
Current Portion of Long-Term Debt |
808
|
750
|
750
|
3 048
|
2 298
|
2 298
|
1 423
|
3 138
|
4 680
|
|
Other Current Liabilities |
3 792
|
8 675
|
6 711
|
6 502
|
7 342
|
6 483
|
6 259
|
7 186
|
10 408
|
|
Total Current Liabilities |
10 992
|
16 253
|
14 214
|
18 002
|
17 127
|
16 737
|
16 011
|
17 650
|
23 968
|
|
Long-Term Debt |
3 250
|
2 500
|
1 750
|
12 970
|
13 671
|
13 747
|
12 323
|
9 185
|
4 505
|
|
Other Liabilities |
7 275
|
7 862
|
7 712
|
7 766
|
7 868
|
7 588
|
6 071
|
5 770
|
342
|
|
Total Liabilities |
21 517
N/A
|
26 615
+24%
|
23 676
-11%
|
38 738
+64%
|
38 666
0%
|
38 072
-2%
|
34 405
-10%
|
32 605
-5%
|
28 815
-12%
|
|
Equity | ||||||||||
Common Stock |
1 197
|
1 197
|
1 197
|
1 197
|
1 197
|
1 197
|
1 197
|
1 197
|
1 197
|
|
Retained Earnings |
34 759
|
37 312
|
39 280
|
40 630
|
39 560
|
41 790
|
45 833
|
49 619
|
56 372
|
|
Additional Paid In Capital |
851
|
851
|
851
|
913
|
928
|
928
|
1 867
|
1 847
|
1 848
|
|
Unrealized Security Profit/Loss |
0
|
2 726
|
3 657
|
3 130
|
2 293
|
2 824
|
3 231
|
4 590
|
4 790
|
|
Treasury Stock |
0
|
2 396
|
2 278
|
2 281
|
2 191
|
2 139
|
3 479
|
3 350
|
3 287
|
|
Other Equity |
420
|
179
|
148
|
133
|
214
|
90
|
243
|
630
|
1 010
|
|
Total Equity |
35 961
N/A
|
39 511
+10%
|
42 559
+8%
|
43 456
+2%
|
41 573
-4%
|
44 510
+7%
|
48 892
+10%
|
54 533
+12%
|
61 930
+14%
|
|
Total Liabilities & Equity |
57 478
N/A
|
66 126
+15%
|
66 235
+0%
|
82 194
+24%
|
80 239
-2%
|
82 582
+3%
|
83 297
+1%
|
87 138
+5%
|
90 745
+4%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|